The price, which is confidential and was negotiated for all in all , 300 million doses, is somewhat less than the $19.50 a photo the United States agreed to pay for a very first shipment of hundred million doses of the identical vaccine, in series with what Reuters claimed in November.
The EU booklet dated Nov. 18 was circulated internally following the EU announced the supply deal of its with Pfizer and the German partner BioNTech of its on Nov. 11.
The EU drug regulator is expected to determine on Monday on endorsement for the Pfizer vaccine after the shot was authorised in a number of countries, including Britain and the United States.
On Thursday Belgian say secretary on your spending budget Eva De Bleeker published on Twitter a dinner table with prices Belgium will pay pharmaceutical companies for the COVID 19 vaccines of theirs. She retracted the post shortly after posting.
In that dining room table the Pfizer vaccine was suggested as costing Belgium 12 euros ($14.6) a dose, leading many to think this was the entire fee agreed by the EU.
Various other vaccines in the family table were furthermore shown with rates lower than rates disclosed by EU sources.
“There is , naturally, a full price along with a price upon delivery,” an EU official required in talks with vaccine creators told Reuters when directed to clarify the difference between the EU and Belgian rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality needs, but pointed to what De Bleeker told the Belgian parliament previous week. In this public hearing, De Beeker said Belgium’s budgeted costs were still partial.
Under EU advance purchase deals for COVID-19 vaccines, the bloc believes upfront payments with businesses to secure doses before they’re approved. Following approvals, EU governments are able to pay the remainder to get reserved doses.
The EU hasn’t revealed the initial payment agreed with Pfizer.
Nonetheless, it mentioned in October that it paid aproximatelly 1 billion euros found in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for their shots, with an additional 1.45 billion euros budgeted for upfront payments to Pfizer-BioNTech, Curevac and Moderna.
It has since agreed supply deals with all 6 corporations and is negotiating a seventh agreement with Novavax.